Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66


Routine Hemostasis and Hemogram Parameters: Valuable Assessments for Coagulation Disorder and Chemotherapy in Cancer Patients.

Zhu YW, Feng TB, Zhou XJ, Hu XL, Ding J, Zhu WY, Qian DP, Sun YW.

Chin Med J (Engl). 2016 Aug 5;129(15):1772-7. doi: 10.4103/0366-6999.186637.


Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?

Woei-A-Jin FJ, Tesselaar ME, Garcia Rodriguez P, Romijn FP, Bertina RM, Osanto S.

Br J Cancer. 2016 Jul 26;115(3):332-8. doi: 10.1038/bjc.2016.170. Epub 2016 Jul 12.


Ultrasensitive microfluidic analysis of circulating exosomes using a nanostructured graphene oxide/polydopamine coating.

Zhang P, He M, Zeng Y.

Lab Chip. 2016 Aug 2;16(16):3033-42. doi: 10.1039/c6lc00279j.


Thymoquinone Modulates Blood Coagulation in Vitro via Its Effects on Inflammatory and Coagulation Pathways.

Muralidharan-Chari V, Kim J, Abuawad A, Naeem M, Cui H, Mousa SA.

Int J Mol Sci. 2016 Mar 30;17(4):474. doi: 10.3390/ijms17040474.


Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm.

Kajdos M, Janas Ł, Kolasa-Zwierzchowska D, Wilczyński JR, Stetkiewicz T.

Prz Menopauzalny. 2015 Dec;14(4):283-91. doi: 10.5114/pm.2015.56540. Epub 2015 Dec 22. Review.


Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.

Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, Bergmeier W, Mackman N.

J Thromb Haemost. 2016 Jan;14(1):153-66. doi: 10.1111/jth.13181. Epub 2015 Dec 11.


Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy.

Tang XJ, Sun XY, Huang KM, Zhang L, Yang ZS, Zou DD, Wang B, Warnock GL, Dai LJ, Luo J.

Oncotarget. 2015 Dec 29;6(42):44179-90. doi: 10.18632/oncotarget.6175. Review.


Microparticles as Biomarkers of Blood Coagulation in Cancer.

Nomura S, Niki M, Nisizawa T, Tamaki T, Shimizu M.

Biomark Cancer. 2015 Oct 1;7:51-6. doi: 10.4137/BIC.S30347. eCollection 2015. Review.


Trousseau's Syndrome, a Previously Unrecognized Condition in Acute Ischemic Stroke Associated With Myocardial Injury.

Thalin C, Blomgren B, Mobarrez F, Lundstrom A, Laska AC, von Arbin M, von Heijne A, Rooth E, Wallen H, Aspberg S.

J Investig Med High Impact Case Rep. 2014 Jun 24;2(2):2324709614539283. doi: 10.1177/2324709614539283. eCollection 2014 Apr-Jun.


A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesicles.

Wu M, Barnard J, Kundu S, McCrae KR.

J Thromb Haemost. 2015 Oct;13(10):1928-40. doi: 10.1111/jth.13072. Epub 2015 Sep 15.


The prothrombotic activity of cancer cells in the circulation.

Mitrugno A, Tormoen GW, Kuhn P, McCarty OJ.

Blood Rev. 2016 Jan;30(1):11-9. doi: 10.1016/j.blre.2015.07.001. Epub 2015 Jul 14.


Simulated Thrombin Generation in the Presence of Surface-Bound Heparin and Circulating Tissue Factor.

Dydek EV, Chaikof EL.

Ann Biomed Eng. 2016 Apr;44(4):1072-84. doi: 10.1007/s10439-015-1377-5. Epub 2015 Jul 14.


The polyphosphate-factor XII pathway drives coagulation in prostate cancer-associated thrombosis.

Nickel KF, Ronquist G, Langer F, Labberton L, Fuchs TA, Bokemeyer C, Sauter G, Graefen M, Mackman N, Stavrou EX, Ronquist G, Renné T.

Blood. 2015 Sep 10;126(11):1379-89. doi: 10.1182/blood-2015-01-622811. Epub 2015 Jul 7.


A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy.

Kholia S, Jorfi S, Thompson PR, Causey CP, Nicholas AP, Inal JM, Lange S.

J Extracell Vesicles. 2015 Jun 19;4:26192. doi: 10.3402/jev.v4.26192. eCollection 2015.


Venous thromboembolism in cancer patients: an underestimated major health problem.

Khalil J, Bensaid B, Elkacemi H, Afif M, Bensaid Y, Kebdani T, Benjaafar N.

World J Surg Oncol. 2015 Jun 20;13:204. doi: 10.1186/s12957-015-0592-8. Review.


Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day.

Gardiner C, Harrison P, Belting M, Böing A, Campello E, Carter BS, Collier ME, Coumans F, Ettelaie C, van Es N, Hochberg FH, Mackman N, Rennert RC, Thaler J, Rak J, Nieuwland R.

J Extracell Vesicles. 2015 Mar 13;4:26901. doi: 10.3402/jev.v4.26901. eCollection 2015.


Clinical significance of procoagulant microparticles.

Nomura S, Shimizu M.

J Intensive Care. 2015 Jan 7;3(1):2. doi: 10.1186/s40560-014-0066-z. eCollection 2015. Review.


Microparticle analysis in disorders of hemostasis and thrombosis.

Mooberry MJ, Key NS.

Cytometry A. 2016 Feb;89(2):111-22. doi: 10.1002/cyto.a.22647. Epub 2015 Feb 20. Review.


Association between micro particle-tissue factor activity, factor VIII activity and recurrent VTE in patients with acute pulmonary embolism.

Kooiman J, den Exter PL, Kilicsoy I, Cannegieter SC, Eikenboom J, Huisman MV, Klok FA, Versteeg HH.

J Thromb Thrombolysis. 2015 Oct;40(3):323-30. doi: 10.1007/s11239-015-1180-z.


Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment.

Penfornis P, Vallabhaneni KC, Whitt J, Pochampally R.

Int J Cancer. 2016 Jan 1;138(1):14-21. doi: 10.1002/ijc.29417. Epub 2015 Jan 23. Review.

Items per page

Supplemental Content

Support Center